Novo Nordisk A/S Common Stock (NVO)
SG&A Expense Growth
23.37%
Quarterly · Period ending:
NVO SG&A Expense Growth
Latest reported23.37%period ending
Latest reported23.37%period ending
NVO Quarterly SG&A Growth (QoQ) (0.00% → 23.37%)
Latest values, visible window
High-resolution chart · PNG
NVO sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 23.3714% | |
| -24.2058% | |
| -2.472% | |
| -5.1409% | |
| 16.9873% | |
| -20.5562% | |
| 22.2336% | |
| 3.1135% | |
| 11.6423% | |
| -22.6189% | |
| 32.3339% | |
| -8.6869% | |
| 14.3217% | |
| -10.6554% | |
| 19.6844% | |
| 6.5759% | |
| 6.0791% | |
| -13.0167% | |
| 26.4123% | |
| 13.9023% | |
| -3.0801% | |
| -16.1985% | |
| 19.4336% | |
| 11.6109% | |
| -3.4284% | |
| -20.9266% | |
| 22.8164% | |
| 4.0085% | |
| 7.3183% | |
| -21.4064% | |
| 24.0323% | |
| 1.4986% | |
| 8.5578% | |
| -22.2883% | |
| 27.3231% | |
| -2.9535% | |
| -1.0649% | |
| -15.1515% | |
| 15.2381% | |
| 1.7442% | |
| 1.1897% | |
| -16.8858% | |
| 16.4494% | |
| -1.9722% | |
| 15.155% | |
| -9.6179% | |
| 14.4334% | |
| 6.5313% | |
| 7.8594% | |
| -22.0458% | |
| 18.9891% | |
| -4.4819% | |
| 5.0229% | |
| -11.8613% | |
| 18.4336% | |
| 1.3875% | |
| 6.3278% | |
| -5.6199% | |
| 8.1459% | |
| 1.8666% | |
| 7.8748% | |
| -10.9217% | |
| 3.473% | |
| 9.9394% | |
| 5.4313% | |
| -9.0469% | |
| 22.8463% | |
| -5.6155% | |
| 0.3607% | |
| 0.3156% | |
| 18.3314% | |
| -1.8041% | |
| 8.2999% | |
| -10.3143% | |
| 8.4037% | |
| -2.5135% | |
| 1.2687% | |
| -7.8636% | |
| 20.2046% | |
| -3.035% | |
| 19.6071% | |
| -18.4464% | |
| 18.6164% | |
| 7.8277% | |
| 4.266% | |
| -8.4452% | |
| 12.8139% | |
| 4.8888% | |
| 1.6203% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |